Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.1350 (0.85%) ($7.1350 - $7.1350) on Wed. Jun. 28, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.8% (three month average) | RSI | 12 | Latest Price | $7.1350(0.85%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | BCRX declines -9.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(36%) BND(27%) VCIT(27%) LQD(25%) IBB(24%) | Factors Impacting BCRX price | BCRX will decline at least -1.4% in a week (0% probabilities). XLRE(-24%) XLP(-22%) TBT(-20%) SPLV(-20%) DIA(-16%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.4% (StdDev 2.8%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-7.72(-208.2%) | Resistance Level | $7.85 | 5 Day Moving Average | $7.05(1.21%) | 10 Day Moving Average | $7.29(-2.13%) | 20 Day Moving Average | $7.85(-9.11%) | To recent high | -19.4% | To recent low | 1.9% | Market Cap | $1.259b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |